Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistLite-Up Anywhere Ltd., a tobacco product company, received a warning letter from the FDA's Center for Tobacco Products in September 2022 regarding violations of the Family Smoking Prevention and Tobacco Control Act. Based on the citation subject line, the company appears to have violated regulations concerning adulterated and/or misbranded tobacco products. Without access to the full warning letter text, the specific nature of these violations cannot be detailed, though they likely relate to product manufacturing standards, labeling requirements, or other regulatory compliance issues under the FDA's tobacco authority.